Trial-specific Patient Decision Aid (tPDA) of the ImmunoSABR Phase 2

Clinical trial NCT04604470 · UNKNOWN

Trial details

NCT number: NCT04604470
Sponsor: Maastricht University
Status: UNKNOWN
Study type: OBSERVATIONAL

NSCLC Stage IV Lung Cancer Non Small Cell Lung Cancer Metastatic Cancer

Start date: 2020-10-20
Primary completion: 2023-10-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.